![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Treating for Stage III NSCLC After Progression on Durvalumab (OncLive) View |
![]() |
Stage III NSCLC: When to Start Durvalumab (OncLive) View |
![]() |
Implications for Using Durvalumab in Stage 3 NSCLC (OncLive) View |
![]() |
Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of Care (BMIC-024) (BeaconMedIC) View |
![]() |
Durvalumab improves PFS in stage III lung cancer (VJOncology) View |
![]() |
How do you manage progression in a patient on durvalumab after chemoradiation for stage III NSCLC (PRECISCA) View |
![]() |
Case Based Panel Discussion - Stage 3 NSCLC Best Schedule - Durvalumab/Imfinzi in Varying Patients (GRACE - Global Resource for Advancing Cancer Education) View |
![]() |
Tips for Managing NSCLC Patients on Durvalumab Therapy (OncLive) View |
![]() |
Refining which patients benefit from consolidation durvalumab for stage III unresectable NSCLC (VJOncology) View |
![]() |
PACIFIC Trial: Durvalumab for Stage 3 NSCLC (OncLive) View |